Irvine, CA, United States of America

Nehal Mahendra Shah


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Nehal Mahendra Shah

Introduction

Nehal Mahendra Shah, based in Irvine, California, is a notable inventor in the field of biomedical sciences. With a focus on innovative compositions and methods, Shah has contributed significant advancements that aim to enhance medical imaging and targeted therapies.

Latest Patents

Shah holds a patent for "Compositions and methods for 18F-fluorodeoxyglycosylamines." This groundbreaking patent outlines various compositions and methods for Quasi-Amadori products, emphasizing the reaction between halogenated carbohydrates and primary amino groups of affinity ligands. A particularly intriguing aspect of this invention is the formation of Quasi-Amadori products from 2-fluorodeoxyglucose paired with affinity moieties that preferentially bind to neural cells or structures. Additionally, the compounds developed under this patent facilitate advancements in PET imaging, showcasing Shah's impact on both research and clinical applications.

Career Highlights

Nehal Mahendra Shah is affiliated with the University of California, where he collaborates with fellow researchers to drive scientific progress. His efforts reflect a commitment to enhancing methodologies that can lead to better understanding and treatment of neurological conditions.

Collaborations

Shah has worked alongside notable colleagues, including Jogeshwar Mukherjee and Aparna Baranwal. Together, they contribute to a thriving research environment that fosters innovation and collaboration, pushing the boundaries of current scientific knowledge.

Conclusion

Nehal Mahendra Shah's work exemplifies the intersection of innovation and practical application in the field of biomedical research. With his patent on Quasi-Amadori products, he continues to pave the way for future advancements in medical imaging and personalized medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…